Back | Next |
home / stock / bcrx / bcrx message board
Subject | By | Source | When |
---|---|---|---|
The sharp increase in revenue is what got | Cosa | investorshub | 10/01/2021 8:02:19 PM |
Facepalm I jinxed you guys. | Cosa | investorshub | 10/01/2021 8:00:36 PM |
Hi Cosa, welcome | bhulkupk | investorshub | 09/29/2021 7:44:32 PM |
Hi, been in since March/april 2020 from $3s. | Deano361 | investorshub | 09/29/2021 7:44:21 PM |
Hello All, new here. Grabbed a little just | Cosa | investorshub | 09/29/2021 7:41:05 PM |
whytestocks: $BCRX News Article - BioCryst Announces Approval of ORLADEYO (berotralstat) in United A | whytestocks | investorshangout | 09/09/2021 6:20:58 PM |
Cant believe with all the recent news especially | easyrider1 | investorshub | 09/02/2021 1:02:06 AM |
Well, its one of my few long 3 | Deano361 | investorshub | 09/02/2021 12:31:30 AM |
Oh okay, so I can buy some for | bhulkupk | investorshub | 09/01/2021 11:43:52 PM |
Its a quote from executive and its all | Deano361 | investorshub | 09/01/2021 1:34:34 PM |
How? | bhulkupk | investorshub | 09/01/2021 1:22:14 PM |
Embarrassment of riches! | Limey42 | investorshub | 09/01/2021 11:19:11 AM |
I think it is a public show of | MZlu | investorshub | 08/11/2021 5:06:36 AM |
Totally agree. No one saw secondary offering | easyrider1 | investorshub | 08/11/2021 3:09:48 AM |
Some crazy shit Stoney pulled off today!!! | Limey42 | investorshub | 08/11/2021 1:59:59 AM |
Today showed power of shortsdropping share price to | easyrider1 | investorshub | 08/06/2021 2:01:08 AM |
I believe $30 per share and likely a | easyrider1 | investorshub | 08/06/2021 1:32:03 AM |
Well into triple digits in 2022-2024 | ttubular | investorshub | 08/05/2021 1:18:33 PM |
This a solid play? Price predictions here for | amonoy1992 | investorshub | 08/05/2021 11:58:26 AM |
The daily dips under $17, set us up | easyrider1 | investorshub | 07/30/2021 11:14:58 AM |
News, Short Squeeze, Breakout and More Instantly...
BioCryst Pharmaceuticals Inc. Company Name:
BCRX Stock Symbol:
NASDAQ Market:
BioCryst Pharmaceuticals Inc. Website:
Monday, BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported a first-quarter earnings loss of $(0.17) per share versus the consensus estim...
2024-05-06 18:47:50 ET For the most part, U.S. stocks had a good Monday, with the bellwether S&P 500 index confidently marching more than 1% higher. But BioCryst Pharmaceuticals (NASDAQ: BCRX) and its investors had a really good day, as the company delivered a first quar...
BioCryst Pharmaceuticals (NASDAQ: BCRX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.23. T...